ORYZON Announces Positive Clinical Data of Iadademstat at ASH-2025
Three iadademstat abstracts have been accepted for presentation at the upcoming ASH-2025 Annual MeetingPreliminary data from the ongoing Phase Ib...
Pharmaceutical
Akebia Therapeutics to Present at Upcoming Investor Conferences
CAMBRIDGE, Mass., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to...
Coalition for Patient Rights Announces Update on Their Inaugural Hoedown Nov. 15; Lead-Up Performance by Country Artist Jonny Hazard at Downtown Container Park Nov. 5
Toy drive with Operation Warm Heart benefits Airmen at Nellis & Creech AFBs; Family fun, food, spirits and beverages made...
Equitech-Bio Extends Global Reach With Bioz Badges, Showcasing Citation Engagement From Researchers
PALO ALTO, CA / ACCESS Newswire / November 4, 2025 / Bioz, Inc., the leader in turning scientific literature into...
BioNxt Reports “Intention to Grant” Patent Notification from the European Patent Office for Its Oral Cladribine Sublingual Thin-Film as the Multiple Sclerosis Market Shifts Toward Patient-Friendly Therapies
VANCOUVER, BC / ACCESS Newswire / November 4, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT) is pleased...
Defence Therapeutics Demonstrates Strong Preclinical in Vivo Efficacy Results Evaluating Accum-Kadcyla in Breast Cancer Models
Montreal, Quebec--(Newsfile Corp. - November 4, 2025) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTCQB: DTCFF) ("Defence" or the...
Cellbxhealth PLC Announces Expert Consensus on CTCs; Update on Funding
Independent Expert Consensus Confirms Clinical Relevance of CTCs and Identifies Parsortix Platform as Leading Next-Generation TechnologyExpert consensus predicts integration of...
Health Union Expands Custom Insights Solutions for Patients and Providers
Health Union's enhanced research suite expands its core patient and caregiver offerings to fully incorporate HCP insights, optimize its unique...
Protagonist Therapeutics Announces Oral and Poster Presentations on Rusfertide at the 67th Annual ASH Meeting
NEWARK, CALIFORNIA / ACCESS Newswire / November 3, 2025 / Protagonist Therapeutics, Inc. ("Protagonist" or the "Company") announced that clinical...
The Assistance Fund Opens New Program for Macular Telangiectasia
Financial Assistance From The Assistance Fund Now Available for Eligible People Living With Macular Telangiectasia ORLANDO, FL / ACCESS Newswire...
Phio Pharmaceuticals Announces Exercise of Warrants for Approximately $13.4 Million Gross Proceeds
King of Prussia, Pennsylvania--(Newsfile Corp. - November 3, 2025) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage siRNA biopharmaceutical company...
Verix Secures U.S. Patent for Dynamic Code Technology Enabling Intelligent Automation in its Flagship Tovana™ Platform
Patented innovation powers adaptive data operations and accelerates commercial optimization for life sciences companies SANTA CLARA, Calif., Nov. 3, 2025...
Sanyou Bio and Shanghai ZJ Bio-Tech Sign Strategic Cooperation Agreement on Automated Development of Innovative Biologics to Jointly Tackle R&D Bottlenecks and Provide New Momentum for Innovative Drug R&D
SHANGHAI, Nov. 3, 2025 /PRNewswire/ -- Sanyou Biopharmaceuticals (Shanghai) Co., Ltd. (hereinafter referred to as "Sanyou Bio") and Shanghai ZJ...
HFA Architecture + Engineering Acquires TRIA, Expanding into Science and Technology Sector
BENTONVILLE, Ark., Nov. 3, 2025 /PRNewswire/ --Â HFA, an employee-owned, nationally recognized architecture and engineering firm, today announced the acquisition of...
Crystallization Strategies for API Development and Scale-Up, Upcoming Webinar Hosted by Xtalks
In this free webinar, learn how crystallization strategies can optimize API development and scale-up. Attendees will understand the importance of...
ArisGlobal Announces NavaX™ Agents Suite
Orchestrated by the NavaX Super Agent, the Suite includes previously launched MedDRA Coding Agent and upcoming cross-domain Agents BOSTON, Nov. 3,...
Partillion Launches Developer Kits, Powering Customer-Led Innovation on Nanovials
LOS ANGELES, Nov. 3, 2025 /PRNewswire/ -- Partillion Bioscience today announced the launch of Developer Kits, a ready foundation for...
Reprieve House Opens Silicon Valley’s First Premium Detox Facility
LOS ALTOS HILLS, CA / ACCESS Newswire / November 3, 2025 / Reprieve House has opened its doors as Silicon...
Medical Care Technologies, Inc (OTC PINK:MDCE) Announces Development of AI-Powered Wellness App Suite with Global Reach
Bringing Next-Generation Wellness to a Global Audience with Multilingual, Accessible AI Solutions MESA, ARIZONA / ACCESS Newswire / November 3,...
CASI Pharmaceuticals Announces Upcoming Presentation of Clinical Results for CID-103 at the 67th American Society of Hematology (ASH) Annual Meeting
- CID-103 is a potential best-in-class, anti-CD38 monoclonal antibody- Phase 1 dose escalation study in Immune Thrombocytopenia (ITP) results and...